NVS Financials: Novartis AG AI Analysis



Financials

NVS Financial

Novartis AG

$150.45

0%

$0

At close: May 20, 16:00:00 GMT-4

$150.5

0.03%

$0.05

Post-market: May 20, 20:00:00 GMT-4

Overview Forecast Earnings Dividends Financials

Key Stats

Prev.Close

$150.44

Open

$150.95

Day's Range

$150.23 - $151.76

52 week range

$104.93 - $170.46

Volume

1.3M

Avg.Volume

2.2M

Dividend yield

EPS (TTM)

7.15

Market Cap

$288.7B

What is Novartis AG?

Novartis AG is a holding company, which engages in the business of developing, manufacturing, and marketing healthcare products. The company is headquartered in Basel, Basel-Stadt and currently employs 75,883 full-time employees. The company went IPO on 2001-05-07. The firm develops, manufactures, and markets branded and generic prescription drugs, active pharmaceutical ingredients (APIs), biosimilars and ophthalmic products. The firm uses science and digital technologies for treatments in the disease areas of immunology, dermatology, cancer, ophthalmology, neuroscience, respiratory, cardiovascular, renal and metabolism. The business activities of the Company are divided into two segments: Innovative Medicines, which includes innovative patent-protected prescription medicines for blood pressure, cancer and other ailments, and Sandoz, which includes generic pharmaceuticals and biosimilars.

Features

Markets

News

Breakdown	TTM	03/31/2026	12/31/2025	09/30/2025	06/30/2025	03/31/2025
Revenue	56,256	13,511	13,860	14,358	14,527	13,585
Revenue Growth (YoY)	6%	-1%	2%	9%	13%	12%
Cost of Revenue	13,834	3,438	3,542	3,535	3,319	3,224
Gross Profit	42,422	10,073	10,318	10,823	11,208	10,361
Selling, General & Admin	13,318	3,137	3,436	3,304	3,441	3,057
Research & Development	10,697	2,704	2,763	2,677	2,553	2,302
Operating Expenses	24,523	5,964	6,268	6,238	6,053	5,575
Other Non Operating Income (Expenses)	-73	4	-57	-7	-13	46
Pretax Income	15,784	3,839	3,218	4,196	4,531	4,407
Income Tax Expense	2,270	683	814	266	507	798
Net Income	13,534	3,156	2,409	3,928	4,041	3,606
Net Income Growth	5%	-12%	-15%	23%	24%	34%
Shares Outstanding (Diluted)	1,916	1,916	1,937	1,940	1,960	1,979
Shares Change (YoY)	-3%	-3%	-4%	-4%	-4%	-4%
EPS (Diluted)	7.06	1.65	1.24	2.02	2.06	1.82
EPS Growth	9%	-9%	-11%	28.99%	30%	39%
Free Cash Flow	15,962	2,869	1,247	5,740	6,106	2,151
Free Cash Flow Per Share	--	--	--	--	--	--
Gross Margin	75.4%	74.55%	74.44%	75.37%	77.15%	76.26%
Operating Margin	31.81%	30.41%	29.22%	31.93%	35.48%	35.23%
Profit Margin	24.05%	23.35%	17.38%	27.35%	27.81%	26.54%
Free Cash Flow Margin	28.37%	21.23%	8.99%	39.97%	42.03%	15.83%
EBITDA	18,304	4,190	4,124	4,772	5,218	4,854
EBITDA Margin	32.53%	31.01%	29.75%	33.23%	35.91%	35.73%
D&A For EBITDA	405	81	74	187	63	68
EBIT	17,899	4,109	4,050	4,585	5,155	4,786
EBIT Margin	31.81%	30.41%	29.22%	31.93%	35.48%	35.23%
Effective Tax Rate	14.38%	17.79%	25.29%	6.33%	11.18%	18.1%

Breakdown

TTM

03/31/2026

12/31/2025

09/30/2025

06/30/2025

03/31/2025

Revenue

56,256

13,511

13,860

14,358

14,527

13,585

Revenue Growth (YoY)

-1%

13%

12%

Cost of Revenue

13,834

3,438

3,542

3,535

3,319

3,224

Gross Profit

42,422

10,073

10,318

10,823

11,208

10,361

Selling, General & Admin

13,318

3,137

3,436

3,304

3,441

3,057

Research & Development

10,697

2,704

2,763

2,677

2,553

2,302

Operating Expenses

24,523

5,964

6,268

6,238

6,053

5,575

Other Non Operating Income (Expenses)

-73

-57

-7

-13

Pretax Income

15,784

3,839

3,218

4,196

4,531

4,407

Income Tax Expense

2,270

683

814

266

507

798

Net Income

13,534

3,156

2,409

3,928

4,041

3,606

Net Income Growth

-12%

-15%

23%

24%

34%

Shares Outstanding (Diluted)

1,916

1,937

1,940

1,960

1,979

Shares Change (YoY)

-3%

-4%

EPS (Diluted)

7.06

1.65

1.24

2.02

2.06

1.82

EPS Growth

-9%

-11%

28.99%

30%

39%

Free Cash Flow

15,962

2,869

1,247

5,740

6,106

2,151

Free Cash Flow Per Share

Gross Margin

75.4%

74.55%

74.44%

75.37%

77.15%

76.26%

Operating Margin

31.81%

30.41%

29.22%

31.93%

35.48%

35.23%

Profit Margin

24.05%

23.35%

17.38%

27.35%

27.81%

26.54%

Free Cash Flow Margin

28.37%

21.23%

8.99%

39.97%

42.03%

15.83%

EBITDA

18,304

4,190

4,124

4,772

5,218

4,854

EBITDA Margin

32.53%

31.01%

29.75%

33.23%

35.91%

35.73%

D&A For EBITDA

405

187

EBIT

17,899

4,109

4,050

4,585

5,155

4,786

EBIT Margin

31.81%

30.41%

29.22%

31.93%

35.48%

35.23%

Effective Tax Rate

14.38%

17.79%

25.29%

6.33%

11.18%

18.1%

Follow-Up Questions

What are Novartis AG's key financial statements?



According to the latest financial statement (Form-10K), Novartis AG has a total asset of $0, Net loss of $0

What are the key financial ratios for NVS?



Novartis AG's Current ratio is 0, has a Net margin is 0, sales per share of $0.

How is Novartis AG's revenue broken down by segment or geography?



Novartis AG largest revenue segment is Other, at a revenue of 2,142,000,000 in the most earnings release.For geography, United States Revenue (Post-Q2 2023 Reporting) is the primary market for Novartis AG, at a revenue of 23,331,000,000.

Is Novartis AG profitable?



no, according to the latest financial statements, Novartis AG has a net loss of $0

Does Novartis AG have any liabilities?



no, Novartis AG has liability of 0

How many outstanding shares for Novartis AG?



Novartis AG has a total outstanding shares of 0

Novartis AG (NVS) Financial

NVS Stock Price Chart

Key Stats

Prev.Close

Open

Day's Range

52 week range

Volume

Avg.Volume

Dividend yield

EPS (TTM)

Market Cap

What is Novartis AG?

Novartis AG (NVS) Financial

NVS Stock Price Chart

Key Stats

Prev.Close

Open

Day's Range

52 week range

Volume

Avg.Volume

Dividend yield

EPS (TTM)

Market Cap

What is Novartis AG?

NVS Income

Follow-Up Questions

What are Novartis AG's key financial statements?

What are the key financial ratios for NVS?

How is Novartis AG's revenue broken down by segment or geography?

Is Novartis AG profitable?

Does Novartis AG have any liabilities?

How many outstanding shares for Novartis AG?